Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Alvogen Launches First Generic Equivalent of CopaxoneTM in Europe
Tuesday, September 06, 2016Alvogen today announced the launch of RemurelTM glatiramer acetate the first generic equivalent of CopaxoneTM in Central and Eastern Europe The product will be marketed as a once daily subcutaneous mg prefilled syringe under the brand name RemurelTM...
OGD2 Pharma and Syndivia launch collaboration to develop an ADC targeting the O-acetyl-GD2 cancer antigen
Tuesday, September 06, 2016OGD Pharma SAS a biotechnology company developing innovative anticancer therapies targeting the Oacetylated form of the GD ganglioside OAcGD today announces a collaboration with Syndivia SAS a biotechnology company that provides bestinclass bioconjug...
AstraZeneca seeks edge over rivals in severe asthma treatment
Tuesday, September 06, 2016AstraZeneca hopes to convince doctors its experimental injection for severe asthma has an edge over two approved rivals after clinical trials data on Monday showed it worked well when given just once every two months The drugmaker has previously fla...
Galapagos gets orphan drug designation in EU for GLPG1690 in idiopathic pulmonary fibrosis
Tuesday, September 06, 2016Galapagos announces today that the European Commission EC has granted GLPG orphan drug designation for the treatment of patients with idiopathic pulmonary fibrosis IPF IPF is a chronic progressive fibrotic disorder of the lungs that typically affect...
U.S. lawmakers question Mylan's Medicaid EpiPen rebates
Saturday, September 03, 2016Two key US congressional committee members on Friday called for an investigation into whether Mylan NV under fire for raising the price of its EpiPen device overcharged the governments lowincome healthcare program for the allergy treatment In a lett...
Merck scraps development of osteoporosis drug due to stroke risk
Saturday, September 03, 2016Merck Co Inc said it would stop developing its experimental osteoporosis drug after an independent analysis confirmed the treatment raises the risk of stroke While the drug odanacatib reduces the risk of osteoporotic fractures the increased risk of...
Novo Nordisk's veteran CEO Lars Rebien Sorensen to step down
Friday, September 02, 2016Novo Nordisks longserving chief executive Lars Rebien Sorensen is to step down early it was announced on Thursday at a time when the worlds largest insulin maker has said it faces increased competition in the US market where it generates about half i...
Third U.S. patent on Teva's MS drug Copaxone invalidated
Friday, September 02, 2016US patent officials on Thursday invalidated a third patent covering Teva Pharmaceutical Industries billion multiple sclerosis treatment Copaxone after cancelling two other patents on the drug last week The ruling came in a challenge at the US Paten...
Roche's new-drug strategy buoyed by lung-cancer study
Friday, September 02, 2016Swiss drugmaker Roche Holding AG seeking to expand uses for its drug Tecentriq beyond bladder cancer said on Thursday a study had shown the new immunotherapy helped people with lung cancer live longer than with chemotherapy The worlds biggest maker...
Takeda joins effort to develop Zika vaccine with U.S. funding
Friday, September 02, 2016Japanese drugmaker Takeda Pharmaceutical Co on Thursday said it is developing a vaccine to prevent the Zika virus which has been linked to severe birth defects and has secured funding from a US government agency Takeda which is also working on vacci...
